ICHCC/LinkedIn
May 2, 2026, 10:24
From Gene Mutation to Clot Risk in Factor V Leiden – ICHCC
Iranian Comprehensive Hemophilia Care Center shared a post on LinkedIn:
- is the most common inherited blood clotting disorder in populations of European descent, caused by a mutation in the \(F5\) gene. It makes blood more prone to clotting (thrombophilia) because the mutated Factor V protein resists inactivation by protein C.
- While most carriers never experience a clot, it significantly increases the risk of deep vein thrombosis (DVT) and pulmonary embolism.”

Stay updated with Hemostasis Today.
-
Jun 16, 2026, 17:36Suhasini Sil: Mitigating Grade III Plateletpheresis Reactions – A Prospective Evaluation
-
Jun 16, 2026, 17:32Presenting Pivotal Phase 3 Sickle Cell Data at EHA 2026- Agios Pharmaceuticals
-
Jun 16, 2026, 16:17Megan Lynch: Thrilled to Join AstraZeneca
-
Jun 16, 2026, 16:00Denise M: Two Partners, One Mission – Securing the Future of Blood
-
Jun 16, 2026, 15:4910 Posts Not To Miss From EHA 2026
-
Jun 16, 2026, 15:48Yan Leyfman: Can a Blood Test Reveal which Cells in Your Body are Aging Fastest?
-
Jun 16, 2026, 15:24Hiteshi K.C. Chauhan: Oral Anticoagulant Reversal in Major Bleeding and Urgent Surgery
-
Jun 16, 2026, 14:50Abdulrahman Nasiri: Honored to Share our Research Contributions at the EHA 2026
-
Jun 16, 2026, 14:49An Overview of Bernard–Soulier Syndrome – ICHCC